Democratic Republic of the Congo declares Ebola outbreak over
The Ebola outbreak that erupted in the Democratic Republic of the Congo’s North Kivu Province in October – the second in 2021 – was today declared over, the national health authorities announced after no new cases were reported at the end of a 42-day countdown, or two incubation periods after the last confirmed case was […]
Emragoed Press Release and News Package: Childhood Cancer Medicines
The World Health Organization and St. Jude Children’s Research Hospital today announced plans to establish a platform that will dramatically increase access to childhood cancer medicines around the world. The Global Platform for Access to Childhood Cancer Medicines, the first of its kind, will provide an uninterrupted supply of quality-assured childhood cancer medicines to low-and […]
Update on National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS)
Under the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) launched in 2010 as part of National Health Mission (NHM), the Union Ministry of Health & Family Welfare provides technical and financial support to the States/UTs based on the proposals received from the States/UTs and subject to the resource […]
Update on COVID-19 Vaccine Manufacturing Capacity
ChAdOx1 nCoV- 19 Corona Virus Vaccine (Recombinant) (COVISHIELD) is manufactured by M/s Serum Institute of India Pvt., Ltd., Pune, while the Whole Virion Inactivated Corona Virus Vaccine (COVAXIN) is manufactured by M/s Bharat Biotech International Limited, Hyderabad. As communicated by the M/s Serum Institute of India, the current monthly vaccine production capacity of Covishield is […]
Efforts Being Taken to Improve Access of the Poor to Health Services under AB-PMJAY
Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) is an entitlement-based scheme. No enrolment or registration of beneficiary is required to avail benefits under the scheme. The beneficiary may directly visit the empanelled hospital (public or private) to avail cashless treatment benefits. The beneficiary may use the following channels to check his/her eligibility under the scheme: […]
More than half a billion people pushed or pushed further into extreme poverty due to health care costs
DUBAI/GENEVA/WASHINGTON DC — 12 December 2021 — New evidence compiled by the World Health Organization and the World Bank shows that the COVID-19 pandemic is likely to halt two decades of global progress towards Universal Health Coverage. The organizations also reveal that more than half a billion people are being pushed into extreme poverty because […]
Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine
The WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine (updated on 9 December) were developed on the basis of advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization and the evidence summary included in the background document. Summary of the recommendations: Countries can now consider using either a […]
Roche presents pivotal data at ASH 2021 for novel cancer immunotherapy mosunetuzumab
Results to be presented for the first time show mosunetuzumab induces high and durable complete response rates in people with follicular lymphoma who have received two or more prior therapies New efficacy data from Roche’s portfolio of cancer immunotherapies demonstrate potential of bispecific antibodies to expand upon current treatment options across several blood cancers Basel, […]
Centre reviews Public Health Response to COVID-19 in the light of emergence of OMICRON and Progress of Vaccination with States/UT
The five-fold strategy of Test-Track-Treat-Vaccinate-adherence to COVID Appropriate Behaviour (CAB) was highlighted as the mainstay of public health response strategy for effective and timely control and management of COVID19 and its variants by Union Health Secretary Shri Rajesh Bhushan as he reviewed the public health preparedness to the Omicron variant of COVID-19 and progress of […]
Approval accorded under Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Medical Devices.
The Medical Device Sector in India suffers from a considerable cost of manufacturing disability vis-à-vis competing economies, inter alia, on account of lack of adequate infrastructure, domestic supply chain and logistics, high cost of finance, inadequate availability of power, limited design capabilities, low focus on research & development (R&D) and skill development, etc. With an […]
